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Human peripheral  blood B  lymphocytes can be activated by pokeweed mitogen 
(PWM) 1, Staphylococcus  aureus  Cowan I, Epstein-Barr virus, or Nocardia  water-soluble 
mitogen (1-4). Of these polyclonal activators, PWM and S. aureus have been shown to 
stimulate both B and T  cells; furthermore, the activation of peripheral blood B cells 
by PWM appears to be T  cell dependent  (5, 6). Nocardia  mitogen, Epstein-Barr virus, 
and  S.  aureus  Cowan  I  have been shown  to be relatively T  cell-independent  B  cell 
activators (2-4). 
Several parameters can be used to evaluate the polyclonal "activation" of human 
peripheral blood B lymphocytes, including immunoglobulin (Ig) production in vitro, 
enumeration of Ig-secreting cells by reverse hemolytic plaque assay, and enumeration 
of intracytoplasmic  Ig-containing  cells  in  stimulated  cultures.  However,  study  of 
human peripheral blood B lymphocyte function in normal and disease states has been 
hampered by the failure of mature human B cells to respond to some classic activators 
of murine  B  cells,  such  as  dextran  sulfate,  tuberculin  (PPD),  and  Escherichia  coli 
lipopolysaccharide (LPS) (7-10). Dextran sulfate activates relatively immature murine 
B cells and results predominantly in increased DNA synthesis; in contrast, PPD acts 
on  relatively mature murine  B  cells and  stimulates  a  marked  increase  in  antibody 
production but only modest DNA synthesis (11). However, PPD and other polyelonal 
B cell activators  (PBA)  that activate mouse B cells do not have the same effects on 
human peripheral blood B lymphocytes. 
The ability to stimulate human B cells selectively would be of considerable value 
for studies of immune function. We describe here a  "new" PBA, i.e., formaldehyde- 
fixed Salmonella paratyphi B, which activates human peripheral blood B cells to produce 
large amounts of Ig but does not stimulate DNA synthesis as measured by incorpo- 
ration of tritiated thymidine. This PBA apparently acts on relatively mature B cells 
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which  differentiate into Ig-secreting cells without  DNA synthesis. Furthermore, its 
action appears to be completely independent of T  cells, since T-depleted cell popu- 
lations respond well to formaldehyde-fixed S. paratyphi B. 
Materials and Methods 
Cell  Preparations.  Human  peripheral  blood  mononuclear cells  (PBL)  were  obtained on 
several  occasions from heparinized blood of each of 12 normal adult volunteers and 5 adult 
patients with  common variable immunodeficiency (CVID)  without  suppressor T  cells,  by 
centrifugation over a Fieoll-Hypaque gradient (Pharmaeia Fine Chemicals, Div. of Pharmaeia, 
Inc., Piscataway, N.J.)  (12). The interface cells were washed twice with RPMI-1640 medium 
(Grand Island Biological Co., Grand Island, N. Y.). For preparation of lymphocyte subpopu- 
lations, PBL were suspended at 5 ×  10S/ml in RPMI-1640 medium supplemented with 20% 
heat-inactivated fetal calf serum (FCS); monocytes were partially removed by incubation of 
10-ml aliquots in Falcon culture dishes (Falcon Labware, Div. of Becton, Dickinson and Co., 
Oxnard, Calif.) at  37°C in a  5% CO2  in air incubator for  1 h.  The nonadherent cells were 
harvested and rosetted with sheep erythrocytes (E)  treated with neuraminidase (13). The E- 
rosetted  cells  and nonrosetted cells  were  separated  by centrifugation on a  Ficoll-Hypaque 
density gradient as  described by Bentwich et  al.  (14). Cells that  failed to  form  E  rosettes 
(population E-) were collected from the interface and washed. The E-rosetted cells (population 
E +) in the pellet were exposed to distilled H20 for 30 s to lyse the erythrocytes and then washed 
with RPMI-1640. The E + and E- lymphocyte populations were rerosetted with neuraminidase- 
treated E and again separated as described above. In the E + preparation, 90-95% of the cells 
formed rosettes  with neuraminidase-treated E; this population was designated as "T-enriched 
cells." In the E- population, only 2-4% of the cells formed rosettes,  and 90% or more were Ig- 
positive by indirect immunofluorescence using F(ab')2 anti-B cell antiserum; this population 
was designated as "B-enriched cells." In additional experiments, Ig  + B cells were isolated by 
rosetting of the E- population with rabbit anti-human Ig antibody-coated human erythrocytes 
(15) followed  by separation on Ficoli-Hypaque. The Ig  + B cells in the pellet were exposed  to 
distilled  H20  for  30  s  to  lyse  the  erythrocytes  and  then  washed  with  RPMI-1640.  The 
complement receptor-bearing B cell populations (C  + B)  were isolated as described by Hunt 
(16). Briefly, the E--enriched populations were rosetted with sheep erythrocytes (SRBC) which 
had been coated with IgM rabbit anti-SRBC antibody followed with complement (EAC). The 
C +  B  cells,  which  formed  rosettes  with  EAC,  were  then  separated  on  Ficoll-Hypaque as 
described above. 
Mitogens  and Bacterial  Suspensions.  PWM  and phytohemagglutinin (PHA)  obtained from 
Grand Island Biological Co.  were used in cell  cultures at  final dilutions of 1:100 and  1:40, 
respectively.  LPS from Salmonella  typhosa (trichloroacetic acid extract) purchased from Sigma 
Chemical Co.  (St. Louis, Mo.) was used at the optimal concentration of 100 #g/ml. Bacteria 
isolated from hospitalized patients were kindly provided from the "bacterial library" of the 
Department  of Microbiology, University of Illinois Medical  Center.  They  were  grown  in 
Trypticase soy broth (Difco Laboratories, Detroit, Mich.) at 37°C for 18-24 h. After culture, 
bacterial suspensions were treated with 10% formaldehyde for at least 4 h at room temperature 
and then heat-killed at 80°C for 5 min. The bacteria were harvested and washed three times 
with sterile saline and resuspended as a  10% stock solution in phosphate-buffered solution. 
Lyrnphoqte  Cultures.  For all stimulation experiments, PBL were resuspended at a concentra- 
tion of 1 ×  106/ml  in RPMI-1640 supplemented with  10% heat-inactivated FCS, 5 mM  L- 
glutamine, 100 U/ml penicillin, and 100 #g/ml streptomycin. Aliquots of 1 ml were cultured 
with  various stimulators in plastic  tubes  (Falcon  2057;  Falcon Labware,  Div.  of Becton, 
Dickinson and Co., Oxnard, Calif.) at 37°C in 5% CO2 in an incubator. 
Measurement  of DNA  Synthesis.  Human PBL  were  cultured according to  the  method  of 
DuBois et al. (17) in Nunc 1090 plastic tubes (Vangard Int., Neptune, N. J.). All cultures were 
pulsed  with  0.5  /~Ci tritiated  thymidine (6  Ci/mmol)  24  h  before  harvesting. Cells  were 
harvested on day 3 when PHA was used as a stimulator and on day 5 when PWM, S. aureus 
Cowan I, or S. paratyphi  B was used.  In some experiments, cultures were harvested at different 
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Quantitation oflg Secreted in Culture Supernatant Fluids.  The amounts of IgG, IgM, and IgA in 
culture supernatant fluids were determined  by laser nephelometry  (18). These were examined 
without dilution  using a commercially available system provided by Hyland Diagnostics, Div. 
Travenol Laboratories,  Costa Mesa, Calif., according to the method described by Pryjma et al. 
(19). Briefly, the calibration  standards were diluted  1:100 before mixing  with  antisera.  The 
culture  supernate  was  assayed  undiluted,  resulting  in  a  100-fold relative  increase  in  the 
sensitivity of the method.  The reference standards  were adjusted  to a range of concentration 
adequate to our needs. In the case oflgG determination,  100-/~1 aliquots of the culture supernate 
and only 50/d of the calibration  standard were used. This provided  an additional  twofold 
increase in sensitivity but only slight error, since these volumes were diluted in 1 ml of  a mixture 
of antibody and antibody diluent  or in blank solution. 
Quantitation of Ig Binding to Bacteria.  Ig was absorbed with bacteria according to the methods 
of Forsgren and Grubb (20). Briefly, 1 ml of the culture  supernate  or 10 ~g myeloma IgG in 
PBS was added to 100 ~1 of bacterial  suspension in PBS supplemented  with 10% bovine serum 
albumin.  After  30 min of incubation with  continuous  shaking  at 37°C in a water bath, the 
bacteria were spun down and supernatant  fluids were filtered  through a 0.45-/~m Millipore 
filter  (Millipore  Corp.,  Bedford,  Mass.).  The  amount  of Ig in  the  supernatant  fluids  after 
bacterial  absorption  was then quantitated by laser nephelometry  (19). 
Results 
Dose Dependence and Kinetics  of Ig Production Induced by Formaldehyde-fixed S. paratyphi 
B.  PBL from normal adult donors were used to test responses to various strains of 
bacteria by measuring the amount of Ig secreted in stimulated cultures. After testing 
30 strains,  we  found  that  S.  paratyphi  B  stimulated  the  production of significantly 
larger quantities of IgM than did PWM or S. aureus Cowan I. 
To determine the optimal concentration of S. paratyphi  B for the activation of PBL, 
various dilutions of the bacterial  suspension  were  cultured  with  PBL for 7 d.  The 
amount of Ig secreted was then  determined by laser nephelometry. The highest  Ig 
production was obtained with a  1:400 dilution of the stock bacterial suspension (- 5 
×  106 microorganism/ml). When this concentration was used, IgM was first detectable 
on day 4 or 5, depending on the donor and culture conditions. IgG and IgA were not 
measurable by laser nephelometry until day 6 or 7. Representative data from one of 
a  dozen experiments  are shown in Table I. IgM was usually detectable in cultures 
stimulated with S. paratyphi  B  1 d earlier than in cultures stimulated with PWM or S. 
aureus Cowan I  (Table  I),  and  greater amounts of IgM were present  at  equivalent 
time points (days 6-10). 
Lack of Mitogenic Effect of Formaldehyde-fixed S. paratyphi B.  To determine whether S. 
paratyphi  B would induce DNA synthesis (mitogenesis), various dilutions of bacterial 
suspension were cultured with PBL. The mitogenic activity was evaluated by tritiated 
thymidine incorporation. PBL cultures stimulated with various dilutions (from 1:400 
to 1:2,000)  of S. paratyphi  B on day 5 or on days 1-7 in time-course studies (Table II) 
showed  no  significant  increase  in  thymidine  uptake.  Thus,  this  bacterium  is  not 
mitogenic to PBL from healthy donors. Similarly, S. paratyphi  B was not mitogenie to 
the B-enriched population isolated from PBL (Table III). 
Comparison of Various Polyclonal B  Cell  Activators.  The ability of S.  paratyphi  B  to 
activate  PBL  to  differentiate  and  mature  into  Ig-secreting cells  was  evaluated  in 
comparison with  PWM, S.  aureus Cowan I, and  LPS.  Using PBL from  12  healthy 
donors, we evaluated Ig production in cultures stimulated with PWM, S. aureus Cowan 
I, S. paratyphi  B, and LPS. Representative data for three subjects are summarized in 
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TABLE  I 
Ig Production on Days 3-10 of Culture in Cultures of PBL Stimulated with  Various 
Polyclonal B  Cell Activators 
Stimulant  Ig class 
Amount of Ig 
Day  Day  Day  Day  Day  Day  Day 
3  4  5  6  7  8  10 
ttg/  culture 
None  IgM  0  0  0  0  0  0  0 
IgG  0  0  0  0  0  0  0 
IgA  0  0  0  0  0  0  0 
S. paratyphi B  IgM  0  0  0.9  2.0  3.0  5.2  9.5 
IgG  0  0  0  0.8  t.2  1.5  4.3 
IgA  0  0  0  0  0.8  1.3  3.8 
S. aureus Cowan I  IgM  0  0  0  0.8  2.0  3.4  5.7 
IgG  0  0  0  1.0  2.0  2.5  4.2 
IgA  0  0  0  1.2  1.3  2.2  3.0 
PWM  IgM  0  0  0  1.0  1.8  2.4  3.4 
IgG  0  0  0  0.8  2.3  3.0  3.2 
IgA  0  0  0  1.2  1.3  2.2  2.8 
TABLE  II 
3  Uptake of[ H]Thymidine  by PBL Stimulated with PHA, S. aureus Cowan I, and S. paratyphi B 
[~HlThymidine uptake 
Stimulant 
Day  I  Day 2  Day 3  Day 4  Day 5  Day 6  Day 7 
cpm * 
None  80 1:20  154 1:30  324 +  52  406 +  32  428 ..t- 42  358 -¢- 40  380 +  32 
S. paratyphiB  75+15  111±24  389±46  380±46  442"1"38  3581:150  408t:38 
S. aureus Cowan I  ND~  ND  ND  ND  8,950 +  1,589  ND  ND 
PHA  ND  ND  37,800 +  570  ND  ND  ND  ND 
•  Mean of triplicate 1: SD. 
:~ ND, not done. 
TABLE  III 
3  Uptake of [  H] Thymidine  by Separated Lymphocyte  Populations  Stimulated with P WM, 
S. aureus Cowan I, and S. paratyphi B 
Lymphocyte  [aH]Thymidine uptake after stimulation with 
population*  None  PWM  S. aureus Cowan I  S. paratyphi B 
cpm* 
PBL  825:1:98  17,369 ±  530  12,277 -1- 621  902 _  108 
E-  264 +  46  520 ±  101  720 ±  61  248 ±  39 
Ig  ÷  162:1:25  469 ±  68  366 ±  52  202 :l: 48 
C ÷  192 +  35  423 ±  72  639 ±  121  217 ±  29 
* PBL,  peripheral  blood  mononuclear cells;  E-,  E-rosette-negative cells enriched  by  two 
cycles of purification; Ig  +, Ig-positive cells enriched by rosetting of E- cells with anti-Ig- 
coated  human erythrocytes and  separating on  Ficoll-Hypaque;  G +,  G-receptor-bearing 
cells enriched by rosetting of E- cells with EAC and separating on Ficoll-Hypaque. 
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TABLE IV 
Comparison of lg Production in Cultures of PBL Stimulated with PWM, 
S. aureus Cowan I, S. paratyphi B, and LPS 
Donor  Stimulant 
Amount of Ig 
IgM  lgG  IgA 
#g/culture 
E.T.  None  0  0  0 
PWM  4.6  5.3  2.4 
S. aureus Cowan I  2.9  3.2  2.4 
S. paratyphi B  5.9  4.0  3.0 
LPS  0  0  0 
W.C.  None  0  0  0 
PWM  3.3  3.9  2.8 
S. aureus Cowan I  4.4  5.9  3.4 
S. paratyphi B  9.4  2.8  3.0 
LPS  0  0  0 
R.C.  None  0  0  0 
PWM  2.8  2.0  2.2 
S. aureus Cowan I  3.5  2.9  2.0 
S. paratyphi B  8.5  2.0  1.8 
LPS  1.6  1.0  1.2 
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IgM than IgG and IgA on day 7. By contrast, PBL stimulated with PWM or S. aureus 
Cowan I usually produced approximately equal amounts of IgM and IgG on day 7. 
Furthermore, the amount of Ig synthesized and released in culture supernates of PBL 
from most of the donors in response to S. paratyphi B was greater than that in culture 
supernates  of PBL stimulated  with  PWM  or S.  aureus  Cowan  I.  Only 2  of the  12 
donors responded to LPS by production of significant amounts of Ig on day 7. 
Polyclonal B  Cell Activation by Formaldehyde-fixed S. paratyphi B.  To determine whether 
the Ig secreted in cultures stimulated with S. paratyphi B consisted of specific antibodies 
against  S.  paratyphi  B  antigen,  the culture supernate was absorbed with  2  ×  109 S. 
paratyphi  B cells as described in Materials  and Methods. The amount of Ig was not 
decreased  significantly  after  absorption,  indicating  little  or  no  specific  antibody 
against  S.  paratyphi  B  (14  vs.  13 #g of Ig after absorption).  When  2  ×  109 S.  aureus 
Cowan I  cells  were used  to absorb  10 #g of human  myeloma IgG under  the same 
conditions, 85% of the IgG was removed; since protein A on S.  aureus Cowan I binds 
human IgG (21), this indicates that 2 ×  109 S. paratyphi B should be enough to absorb 
almost  all  specific  antibodies  in  the  culture  supernate.  Taken  together,  our  data 
indicate that S. paratyphi  B is a  polyclonal B cell activator which does not stimulate 
specific antibody production against bacterial antigens. 
Response  of B  Cells  to  Formaldehyde-fixed  S.  paratyphi  B.  S.  paratyphi  B  stimulated 
peripheral  blood  B  lymphocytes  to  mature  into  Ig-seereting  cells  without  DNA 
synthesis  (Tables  I  and  II), suggesting that  cell  proliferation  is  not  necessary for B 
lymphocyte maturation  after S.  paratyphi  B  stimulation.  In addition,  the bacterium 
activated  PBL to  produce mainly IgM during the  first  days of cultures  (Table  I). 
Taken  together,  these  data  indicate  that  the  B  cell  response  to  S.  paratyphi  B  is  T 
independent. To confirm this point, we isolated B lymphocytes from PBL and tested 
their  response to S.  paratyphi  B.  B-enriched cell cultures produced large amounts of 370  POLYCLONAL  B  CELL  ACTIVATION BY  S.  PARATYPHI B 
IgM when stimulated with S. paratyphi B but not when stimulated with PWM (Table 
V).  Because more IgM was secreted by the B-enriched population  than  by unfrac- 
tionated PBL stimulated with S. paratyphi B, these data indicate that the response of 
PBL to this PBA is indeed relatively T  cell independent. 
Effects  of  Polyclonal  B  Cell  Activators  on  Cells  from  Patients  with  Intrinsic  B  Cell 
Defects.  Patients with CVID have severe hypogammaglobulinemia involving all Ig 
classes.  Waldmann  et  al.  (22)  have  reported  that  lymphocytes  from  some  CVID 
patients do not  respond to PWM,  and that T  lymphocytes from some patients can 
suppress terminal  differentiation of normal lymphocytes. More recently it has been 
reported that although suppression was demonstrable in some cases of CVID, it could 
not be a major factor in the majority (23). 
Because PWM is a T-dependent PBA, its use as a test substance would not permit 
the  distinction  of a  "pure"  B  cell  defect  from a  suppressor effect in  patients with 
CVID. By contrast, S. paratyphi  B  appears to be a  T-independent  PBA, and its use 
should allow a  much clearer delineation of the level of the B cell defect. If a patient 
with CVID has PBL which are unable to respond because of the absence of efficient 
macrophages,  inadequate  T  cell  help,  or  excessive  suppressor  T  cells,  the  B  cells 
should still be activated polyclonally by S. paratyphi B, whereas PWM should produce 
limited or no stimulation, as has often been observed. 
We conducted a preliminary analysis of the responses to PWM, S.  aureus Cowan I, 
and S. paratyphi B by PBL from CVID patients. Of six adult patients with CVID seen 
by us in the past few months, five had no evidence of suppressor T  cells or suppressor 
monocytes and were willing to return for repeated study. As shown in Table VI, their 
PBL did not respond to S. paratyphi B by measurable Ig production. In contrast, PBL 
from two of the patients responded well to S.  aureus  Cowan I, which has been shown 
to be relatively T  independent  (19), and responded partially to PWM. When B cells 
isolated from the PBL of patients  1,  3,  and  5 were tested, no Ig production  by the 
enriched B cells was detectable, even in the presence of T  cells isolated from normal 
adults.  Thus,  the response to S.  paratyphi  B  provided better discrimination  between 
normal  and  CVID B  cells  than  did  PWM  or S.  aureus  Cowan  I;  furthermore,  no 
morphologic changes in the CVID B cells were seen after stimulation. 
TABLe V 
Effects of Depletion of T and B Lymphocytes on the Response to PWM and 
S. paratyphi B 
Amount of Ig 
Cell  population  Stimulant tested 
IgM  IgG  IgA 
~g/culture 
PBL  None  0  0  0 
PBL  PWM  2.0  1.5  2.1 
PBL  S. paratyphi B  2.2  t,0  2.0 
B-enriched cells  PWM  0.8  0  0 
B-enriched cells  S. paratyphi B  3.2  0  2,2 
B and T  cells*  PWM  9.0  1,6  3.5 
B and T  cells  S. paratyphi B  3.2  0.9  2.0 
T-enriched cells  PWM  0  0  0 
T-enriched cells  S. paratyphi B  0  0  0 
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TABLE  VI 
Responses of PBL from Five Patients with Common  Variable  Immunodefidency 
to PWM,  S. aureus  Cowan 1, and S. parathyphi B 
Patient  Stimulant 
Amount of Ig 






Control (5 pooled) 
tLg/culture* 
None  0  0  0 
PWM  0.6  0  0 
S. aureus Cowan I  2.1  0  0 
S. paratyphi B  0  0  0 
None  0  0  0 
PWM  2.0  0  1.2 
S. aureus Cowan I  3.8  0  1.5 
S. paratyphi B  0  0  0 
None  0  0  0 
PWM  0  0  0 
S. aureus Cowan I  0  0  0 
S. paratyphi B  0  0  0 
None  0  0  0 
PWM  0  0  0 
S. aureus Cowan I  0.8  0  0 
S. paratyphi B  0  0  0 
None  0  0  0 
PWM  0  0  0 
S. aureus Cowan I  0  0  0 
S. paratyphi B  0  0  0 
None  0  0  0 
PWM  4.1  2.2  2.8 
S. aureus Cowan I  4.0  2.0  2.1 
S. paratyphi B  5.8  1.8  1.7 
* Determined in 7-d cultures. 
Discussion 
Our results indicate that  formaldehyde-fixed S. paratyphi B, a  new PBA, activates 
normal human  peripheral  blood B  lymphocytes to produce large amounts of Ig in 
culture without a significant increase in DNA synthesis and with no requirement for 
T  cell collaboration. This is  the first description of a  human  PBA which  does not 
induce  lymphocyte DNA  synthesis.  Our  findings  support  the  dissociation  of cell 
proliferation from polyclonal activation (Ig synthesis), as has been reported in mice 
(24) and proposed for human PBL (25-27). 
Because DNA synthesis is not  required for B cell activation by S. paratyphi  B, it 
could be argued that the bacterium may simply enhance Ig production by preexisting 
Ig-secreting ceils. If this were the case, however, Ig production would be detectable as 
early as day 1 or day 2 after stimulation, and there would not be a significant increase 
in the number of plaque-forming cells in later days. Our data show that Ig production 
in  cultures  stimulated  with  S.  paratyphi  B  was  first  detectable only on  day  4.  In 
addition, IgM plaque formation was first detected on day 3 and reached a maximum 
on day 6 (2,100 -+ 300 and  12,960 +_ 480, respectively). On the other hand, IgM was 
detectable  in  cultures  stimulated  with  S.  paratyphi  B  1 d  earlier  than  in  cultures 
stimulated  with  PWM  or S.  aureus Cowan  I  (Table  I),  and  our preliminary  data 372  POLYCLONAL  B  CELL  ACTIVATION  BY  S.  PARATYPHI  B 
indicate that significant numbers of IgM plaque-forming cells appeared  1 d  earlier 
than in cultures stimulated with PWM or S. aureus Cowan I. These data suggest that 
the cells responding to S. paratyphi B are more differentiated toward Ig-secreting cells 
than are the cells responding to PWM or S. aureus. Thus, the responding cells may be 
immediate precursors of Ig-secreting cells. 
The mechanism by which S. paratyphi B induces Ig synthesis by human B cells is 
not clear. Our data (Table IV) indicate that the PBL response to LPS differs from the 
response to S. paratyphi B, and most strains of G(-) bacteria containing LPS that we 
tested  did  not  activate  human  PBL  (unpublished  data).  Thus,  it  is  likely  that 
activation  is  due  to  components of the  cell wall  other  than  LPS.  In  addition,  S. 
paratyphi  B  binds  all  human  peripheral  blood B  lymphocytes (Dr.  M.  Teodorescu, 
personal communication), and it may be that activation is due to their binding to the 
bacterium. Our preliminary data show higher Ig production in cultures centrifuged 
to promote rosette formation between the bacteria and iymphocytes than in mixtures 
incubated without centrifugation, suggesting that close contact between this bacte- 
rium and B lymphocytes is indeed important for the activation process. 
We have shown that the B cell response to S. paratyphi B is relatively T  independent 
(Table V). Our preliminary data further confirmed that human cord blood lympho- 
cytes responded strongly to this bacterium but  not  to PWM.  Because human cord 
blood lymphocytes contain large numbers of suppressor cells (28, 29), the response of 
cord blood lymphocytes to S. paratyphi B indicates that  the responding cells are not 
influenced by suppressor T  cells.  By contrast, in  five patients  with  CVID without 
elevated suppressor cell activity in their PBL, no Ig was detected on day 7 in cultures 
stimulated with S. paratyphi B. The number of T  cells with Fc receptors for IgG in the 
patients'  PBL cultures was virtually nil, and no suppressor effects by autologous T 
cells were detectable by Waldmann's  technique (22).  In addition, the numbers of T 
and B cells in our five patients with CVID were within the normal range. Thus, it is 
possible that CVID patients lack the B cell subpopulation capable of responding to 
S. paratyphi B. 
In conclusion, formaldehyde-fixed S. paratyphi B appears preferable to other avail- 
able PBA for the comparative analysis of human B cell function in normal and disease 
states,  in that  it is relatively T  cell independent and stimulates higher levels of Ig 
secretion than do other PBA. Furthermore, this new PBA should facilitate investiga- 
tions of (a)  B cell defects manifesting clinically as "agammaglobulinemia," and  (b) 
the ontogeny of the human humoral immune response. 
Summary 
A  "new" polyclonal activator of human  peripheral blood B  cells, formaldehyde- 
fixed  Salmonella  paratyphi  B,  is  described.  This  bacterium  does  not  stimulate  cell 
proliferation as measured by incorporation of tritiated thymidine but does stimulate 
a subpopulation of B cells to secrete large amounts of IgM, IgG, and IgA in 7-d cell 
cultures. The immunoglobulins (Ig) produced by cells responding to S. paratyphi B are 
not specific antibodies against the bacterial antigens. In comparison with other B cell 
activators (pokeweed mitogen, Staphylococcus aureus Cowan I, and lipopolysaccharide), 
S.  paratyphi  B  stimulation  produced  greater  amounts  of IgM  but  less  IgG  than 
pokeweed mitogen (PWM) or S. aureus Cowan I; lipopolysaeeharide failed to stimulate CHEN, MUI~IOZ, FUDENBERG,  TUNG,  AND VIRELLA  373 
significant  Ig production  on  day  7  in  most  cases.  In  addition,  the  response  to  S. 
paratyphi  apparently  did  not  require  T  cell collaboration.  These results suggest  that 
the B cell subpopulation(s)  responding to S. paratyphi B may be more differentiated B 
cells  than  those  responding  to either  PWM  or S.  aureus  Cowan  I.  Peripheral  blood 
mononuclear cells from five patients with common variable immunodeficiency with- 
out  evidence  of abnormal  suppressor  T  cells  or monocytes  failed  to  respond  to S. 
paratyphi  B, whereas  cells  from two of the same patients  responded  well  to S.  aureus 
Cowan I and partially to PWM. Thus, S. paratyphi B appears to be superior to other 
B cell activators for studies of B cell function in normal and abnormal states. 
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